8-K

Company

Alaunos Therapeutics, Inc.

Filed

June 10, 2025

Period of Report

June 9, 2025

Accession Number

0000950170-25-083913

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →